Plasma levels of interleukin-6, interleukin-10, and interleukin-1 receptor antagonist in depression: comparison between the acute state and after remission. — Marta Kubera (2000) | RDL Network
Plasma levels of interleukin-6, interleukin-10, and interleukin-1 receptor antagonist in depression: comparison between the acute state and after remission.
Article 2000 en
Authors
MK
Marta Kubera
GK
Günter Kenis
EB
E. Bosmans
Abstract
1 min read
There is now some evidence that major depression is accompanied by an immune response with an increased production of pro-inflammatory cytokines. The aim of the present study was to examine serum level of cytokines: interleukin-6 (IL-6), which is considered pro-inflammatory one and anti-inflammatory cytokines: interleukin 10 (IL-10), and interleukin-1 receptor antagonist (IL-1Ra) in acute clinical state of depression and after 6-week antidepressant treatment. Serum IL-6, IL-10, IL-1Ra levels were higher in the subjects with major depression than in normal controls although these results were not statistically significant. The mean score according to the Hamilton Depression Rating Scale (HDRS) in the patients significantly decreased during the 6 weeks of the study, demonstrating an overall improvement. Successful antidepressant treatment had no significant effect on serum level of this cytokines.
Rick van Minkelen, Stephanie Bezzina Wettinger, Marieke C. Visser, Hans L. Vos, Pieter H. Reitsma, Frits R. Rosendaal, Rogier M. Bertina, Carine J.M. Doggen
Discussion(0)
No comments yet. Be the first to comment.